The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Novartis; Roche
Consulting or Advisory Role - SERVIER
Research Funding - Celgene; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
A phase 1 study of ramucirumab (R) plus pembrolizumab (P) in patients (pts) with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma, non-small cell lung cancer (NSCLC), or urothelial carcinoma (UC): Phase 1a results.
 
Roy S. Herbst
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; NovaRX; pfizer
Consulting or Advisory Role - Biothera; DiaTech Oncology; Endocyte; Kolltan Pharmaceuticals; N-of-One
Research Funding - Genentech/Roche
 
Johanna C. Bendell
No Relationships to Disclose
 
Nicolas Isambert
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Merck Serono
 
Emiliano Calvo
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Lilly/ImClone; Nanobiotix; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen Oncology; Lilly; Merck; Millennium; Nektar; Novartis; OncoMed; Pfizer; PharmaMar; PsiOxus Therapeutics; Puma Biotechnology; Roche/Genentech; Sanofi; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Lilly; Novartis; PsiOxus Therapeutics
Other Relationship - Pierre Fabre
 
Rafael Santana-Davila
Consulting or Advisory Role - Eisai; Seagen
Research Funding - Genentech (Inst); Lilly (Inst)
 
Philippe Cassier
No Relationships to Disclose
 
Jose Luis Perez-Gracia
Research Funding - Lilly
 
Jing Yang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Jessicca Rege
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
David Ferry
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Gu Mi
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Ian Chau
Honoraria - Amgen; Amgen; Bayer; Bayer; Lilly; Lilly; Pfizer; Pfizer; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Gilead Sciences; Lilly; Merck Serono; Merck Serono; MSD; MSD; Sanofi
Research Funding - Janssen-Cilag; Merck Serono; Roche; Sanofi